+86-28-82633987sales@biopurify.com
cnen
  • iso9001 iso9001
  • iso17025 iso17025
  • usp usp
Alternate Text
Home > Product Catalog > Compound Types > Phenols

Prim-O-glucosylcimifugin

CAS No.:80681-45-4

Prim-O-glucosylcimifugin
Catalogue No.: BP1139
Formula: C22H28O11
Mol Weight: 468.455
Contacts
+86-28-82633860  +86-18080483897
skype skype
Email: sales@biopurify.com biopurify@gmail.com

Prim-O-glucosylcimifugin

CAS No.:80681-45-4

Prim-O-glucosylcimifugin
Catalogue No.: BP1139
Formula: C22H28O11
Mol Weight: 468.455
Contacts
+86-28-82633860  +86-18080483897
skype skype
Email: sales@biopurify.com biopurify@gmail.com
Over 15 years of industry experience in phytochemicals from R&D(reference substances) to Industrialization, please feel free to contact us!


Product name: Prim-O-glucosylcimifugin
Synonym name: Cimifugin 7-glucoside
Catalogue No.: BP1139
Cas No.: 80681-45-4
Formula: C22H28O11
Mol Weight: 468.455
Botanical Source: Angelica, Diplolophium, Eranthis, Ledebouriella and Saposhnikovia spp
Physical Description: Powder
Type of Compound: Flavonoids

Purity: 95%~99%
Analysis Method: HPLC-DAD or/and HPLC-ELSD
Identification Method: Mass, NMR
Packing: Brown vial or HDPE plastic bottle

Storage: Store in a well closed container, protected from air and light. Put into refrigerate or freeze for long term storage.
Whenever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20℃. Generally, these will be useable for up to two weeks.

The product could be supplied from milligrams to grams, up to kilograms
Inquire for bulk scale.

Descriptions:
Prim-O-glucosylcimifugin is main medicinal component of the traditional Chinese drug Saposhnikovia divaricata, can increase concentrations of astragaloside IV and atractylenolide I in the serum, when they were given together.[1]
Prim-O-glucosylcimifugin has inhibition on NO production and DPPH free radical.[2]
Prim-O-glucosylcimifugin and 4′-O-β-D-glucosyl-5-O-methylvisammin-ol con can inhibit the proliferation of smooth muscle cell stimulated by TNF-α and increase the proportion of G0/G1 phase.[3]

References:
[1] Song J, Zheng S R, Jin Y, et al. Planta Med, 2014, 80(3):187-92.
[2] Bo Z, Xin B Y, Xiu W Y, et al. J Asian Nat Prod Res, 2012, 14(9):886-96.
[3] Wang L, Liang R X, et al. China J Chinese Materia Medica, 2008, 33(17):2157-60.
[4] Pin R, Fang B, Li P, et al. Guiding J Trad Chinese Med Pharm, 2010, 16(11):84-6.


Related Products